Abstract
There is an increasing recognition of the need for a specialized hepatohematology program in countries with a high prevalence of sickle cell disease. This program would be tailored specifically for patients with sickle cell disease, addressing the unique challenges they face, including the management of liver and biliary complications, and hematological issues associated with their condition. By integrating hepatology and hematology expertise, we can improve knowledge of liver SCD-related diseases, and patient outcomes, enhance care coordination, and provide comprehensive management strategies for this vulnerable population. While the primary focus of this program is on SCD-related liver disease, there may be opportunities shortly to expand its scope to include patients with various hematological liver diseases.
Cite this Article (APA)
Bandar, A., Hazzaa, A., Ali, A., Fahad, A., Ali, A., Waleed, A., Saad, A., Ibrahim, A., Shaykhah, A., Nour, A., Fuat, S., Christophe, D. (2025). Emerging need for a hepato-hematology program for patients with sickle cell disease in Saudi Arabia. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_419_24
